TABLE 3.
Effect of the nontoxic microbicide and placebo formulations on long-term epithelial cell line viability
| Product | % Viability of epithelial cell linesa
|
|||
|---|---|---|---|---|
| Caco-2 | SW837 | HEC-1-A | ME-180 | |
| CAP | 90 | 102 | 85 | 134 |
| Carraguardb | 50 | 71 | ND | ND |
| Methylcellulose | 99 | 78 | 82 | 142 |
| PRO 2000 4% | 89 | 79 | 73 | 112 |
| PRO 2000 0.5% | 94 | 80 | 94 | 110 |
| PRO 2000 placebo | 82 | 100 | 93 | 108 |
| KY-N9 | 96 | 85 | 71 | 83 |
| KY Jelly | 99 | 68 | 72 | 99 |
| SPL7013 5% | 58 | NDc | 68 | ND |
| SPL7013 placebo | 76 | ND | 72 | ND |
| UC781 1% | 94 | 89 | 85 | 109 |
| UC781 0.1% | 90 | 77 | 94 | 80 |
| UC781 placebo | 88 | 89 | 85 | 109 |
| Vena Gel | 65 | 92 | 76 | 80 |
| Vena Gel placebo | 84 | 65 | 90 | 91 |
Epithelial cells were exposed to the 24-hour nontoxic concentration of each product for 2 h a day for 5 days. Percent viability shown was determined on the fifth day.
Percent viability of Carraguard was determined by trypan blue exclusion.
ND, not determined.